Please provide your email address to receive an email when new articles are posted on . Berotralstat lowered the rate of hereditary angioedema attacks in those with five or more, two to four and one ...
Research in information security, risk management and investment has grown in importance over the last few years. However, without reliable estimates on attack probabilities, risk management is ...
AXS-12 reduced the frequency of cataplexy attacks per week compared with placebo (P =.017). Topline results were announced from a phase 3 trial evaluating AXS-12 (reboxetine) in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results